Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02828878

Recruitment Status : Unknown

Verified November 2019 by Cellect Biotechnology.
Recruitment status was: Recruiting

First Posted : July 12, 2016

Last Update Posted : November 26, 2019

Sponsor:

Information provided by (Responsible Party):

Cellect Biotechnology

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	July 2020
Estimated Study Completion Date :	July 2020

To Top